Investigator Led Studies (ILS), also known as Investigator Initiated Studies (IIS), are independent research projects that are initiated and managed by investigators. ILS are conceived, designed, and executed by the investigator, who assumes the role of sponsor. In ILS arrangements, Revvity typically provides product support, scientific collaboration, or other resources without taking on sponsorship responsibilities. As the study sponsor, the investigator must ensure that all legal and regulatory requirements are met and that the study is conducted and managed in accordance with all applicable laws and regulations.
Revvity's ILS program overview
We understand that discoveries emerge when independent researchers explore transformative ideas. Through our ILS program, we would provide program oversight and offer comprehensive tailored support including:
- Diagnostic products
- Research reagents
- Strategic grant funding
- Advanced instrumentation on a case-by-case basis
ILS research support empowers independent researchers to transform promising ideas into impactful discoveries and help improve patients' outcomes.
Our strategic partnership capitalizes on each participating site's specialties, competencies, and clinical datasets. The ILS partnership model provides Revvity with:
- Review of Proposals: Evaluation of research proposals within ILS timeframes.
- Investigator Study Updates: Ongoing investigator reports throughout the ILS lifecycle.
- Shared Study Data: Transparency to study data in support of Revvity's internal R&D initiatives.
- Manuscripts/Publications: Oversight and support ILS Manuscripts prior to publication.
Our areas of interest
Revvity's ILS program is open to qualified researchers who are interested in conducting studies which aim to broaden clinical and scientific insights and deepen understanding of our solutions within the priority therapeutic areas listed below.
Tuberculosis (T-SPOT™.TB)
- Tuberculosis infection testing
- Non-TB mycobacteria infection testing
Cytomegalovirus (T-SPOT™.CMV)
- Interventional studies
- Congenital CMV
- Transplant
Other studies
Studies to explore performance of T-SPOT technology-based tests.
Who can participate in Revvity's ILS program?
Clinicians affiliated with hospitals, health systems, or private practices
Academic researchers or investigators from universities or research institutions
Clinical fellows or postdoctoral researchers (with institutional oversight)
Multi-disciplinary teams conducting collaborative studies
The ILS process
Check your eligibility
- Appropriate infrastructure and resources in place to conduct the proposed study i.e., scientific, technical, statistical, operational capabilities, and trained staff.
- Have obtained IRB/Ethics approval or prepared to secure approval following ILS proposal approval.
- Clinical research experience evidenced by CV, GCP training, etc.
- Able to meet all regulatory requirements (e.g., final study reports and manuscripts) and to publish in a peer-reviewed scientific journal.
Submit your proposal
Click "I want to submit a proposal" down below to access our ILS proposal form where you can begin the application process.
Submission requirements:
- Ensure your study objectives align with our areas of interest.
- Include all required supporting documentation: protocol, CV, IRB approval (if available), budget (if applicable), W-9 (if receiving funding).
- All documents submitted must be in the English language.
Internal review
- All proposals undergo evaluation by Revvity's Investigator-Led Study Committee.
- The committee assesses scientific merit, feasibility, and strategic alignment.
- The final project review timeline will be defined during proposal discussion.
Feedback and clarifications
The ILS program internal review process will evaluate the following:
- Scientific rigor and innovation
- Alignment with our therapeutic areas and research objectives
- Feasibility of study design and timeline
- Potential for meaningful clinical or scientific impact
Following the committee's monthly review, you will receive notification of the decision along with feedback and, if approved, details regarding support parameters and collaboration terms will be provided.
Final approval and agreement
- Approval: If your proposal is approved, you will receive a formal agreement outlining support parameters, deliverables, timelines, and collaboration terms.
- Agreement finalization and execution: Both parties must sign before study initiation
- Support activation: Resources and materials are provided per agreed terms.
All approved studies require executed agreements before any support begins.
Launch and collaboration
Following committee approval, we initiate a structured collaboration process:
- Study launch - Activate resources, materials, and dedicated support team upon agreement execution.
- Ongoing collaboration - Establish regular communication channels, progress reviews, and milestone checkpoints with assigned Revvity liaison.
- Knowledge sharing - Participate in periodic collaboration meetings and contribute to our research community.
For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
